FP-1069

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NameFP-1069
Drug Alias NameIL-34 inhibitor (FivePrime Therapeutics)FPT-069FP-1069
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionInterleukins inhibitorsAngiogenesis inhibitorsBone modulators +[4
TargetsInterleukins
Therapy Area/IndicationsAutoimmune DiseasesMultiple SclerosisBone Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesFive Prime Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesFive Prime Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsAutoimmune DiseasesMultiple SclerosisBone Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A